- Home
- INM vs PLYM Comparison
INM vs PLYM Comparison
Compare INM & PLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- PLYM
- Stock Information
- Founded
- INM 1981
- PLYM 2011
- Country
- INM Canada
- PLYM United States
- Employees
- INM N/A
- PLYM N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- PLYM Real Estate Investment Trusts
- Sector
- INM Health Care
- PLYM Real Estate
- Exchange
- INM Nasdaq
- PLYM Nasdaq
- Market Cap
- INM 5.0M
- PLYM 983.3M
- IPO Year
- INM N/A
- PLYM 2017
- Fundamental
- Price
- INM $1.85
- PLYM $21.96
- Analyst Decision
- INM
- PLYM Hold
- Analyst Count
- INM 0
- PLYM 8
- Target Price
- INM N/A
- PLYM $21.14
- AVG Volume (30 Days)
- INM 105.5K
- PLYM 1.4M
- Earning Date
- INM 11-13-2025
- PLYM 10-31-2025
- Dividend Yield
- INM N/A
- PLYM 4.37%
- EPS Growth
- INM N/A
- PLYM 439.08
- EPS
- INM N/A
- PLYM 2.89
- Revenue
- INM $4,942,633.00
- PLYM $171,801,000.00
- Revenue This Year
- INM N/A
- PLYM $1.88
- Revenue Next Year
- INM N/A
- PLYM $9.24
- P/E Ratio
- INM N/A
- PLYM $7.60
- Revenue Growth
- INM 7.50
- PLYM N/A
- 52 Week Low
- INM $1.72
- PLYM $12.70
- 52 Week High
- INM $8.27
- PLYM $22.65
- Technical
- Relative Strength Index (RSI)
- INM 30.46
- PLYM 56.36
- Support Level
- INM $1.80
- PLYM $21.82
- Resistance Level
- INM $2.14
- PLYM $22.03
- Average True Range (ATR)
- INM 0.10
- PLYM 0.23
- MACD
- INM -0.03
- PLYM -0.08
- Stochastic Oscillator
- INM 4.46
- PLYM 64.33
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About PLYM Plymouth Industrial REIT Inc.
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.